| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 01/10/2007 | CN1894238A Diamine derivatives |
| 01/10/2007 | CN1894234A 二肽基肽酶抑制剂 Dipeptidyl peptidase inhibitors |
| 01/10/2007 | CN1893977A Remedies for diseases with bone mass loss having ep4 agonist as the active ingredient. |
| 01/10/2007 | CN1893970A Beta-amyloid-analogue-cell epitop vaccine |
| 01/10/2007 | CN1893967A Leukocyte internalized peptide-drug conjugates |
| 01/10/2007 | CN1893941A Fused-ring compounds and use thereof as drugs |
| 01/10/2007 | CN1893929A Extended release venlafaxine formulation |
| 01/10/2007 | CN1893827A Silver dihydrogen citrate compositions comprising a second antimicrobial agent |
| 01/10/2007 | CN1294131C Pyrimidine compound |
| 01/09/2007 | US7160997 Identifying polymerase chain reaction primer extension products using fluorescence energy transfer (FET); detecting allelic variation/restriction fragment length polymorphisms |
| 01/09/2007 | US7160911 Diarylcycloalkyl derivatives, process for their preparation and their use as pharmaceuticals |
| 01/09/2007 | US7160870 Thrombopoietin mimetics |
| 01/09/2007 | US7160537 Preparation of [18F]-fluoro-3'-deoxy-3'-L-fluorothymidine by fluorinating a Boc-protected 3'-deoxythymidine substituted in the 3' position with a leaving group and removing the amine protecting group |
| 01/09/2007 | US7160294 Systems and methods for treating hemorrhoids |
| 01/09/2007 | US7160245 Method and device for umbilicus protection during abdominal surgery |
| 01/09/2007 | CA2375372C Mutual prodrugs of amlodipine and atorvastatin |
| 01/09/2007 | CA2344248C 4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinolines as cetp inhibitors |
| 01/09/2007 | CA2294033C Pharmaceutical composition for acidic lipophilic compounds in a form of a self-emulsifying formulation |
| 01/09/2007 | CA2293797C Aqueous carrier systems for water-insoluble materials |
| 01/09/2007 | CA2142126C Inhalation powder containing antistatic agent |
| 01/04/2007 | WO2005048922A3 Sulfonylaminovalerolactams and derivatives thereof as factor xa inhibitors |
| 01/04/2007 | WO2005009359A3 Agents, compositions and methods for enhancing neurological function |
| 01/04/2007 | WO2004098539A3 Kinases and phosphatases |
| 01/04/2007 | WO2004096121A3 Compositions and methods for preventing infection |
| 01/04/2007 | WO2004082610A3 Modulation of hyaluronan and cd44 interaction and uses thereof in treating disorders |
| 01/04/2007 | US20070005005 Method and apparatus for dosing solids |
| 01/04/2007 | US20070004803 Compounds and methods for use in treating neoplasia and cancer based upon inhibitors of isoprenylcysteine methyltransferase |
| 01/04/2007 | US20070004791 (1 alpha ,5 alpha ,6 alpha )-N-[3-benzyl-3-azabicyclo[3.1.0]hexyl-6-(aminomethyl)-yl]-2-hydroxy-2,2-diphenyl acetamide; high affinity towards Muscarinic 3 receptors; avoiding adverse side effects; for the treatment of various diseases of the respiratory, urinary and gastrointestinal systems |
| 01/04/2007 | US20070004771 Preparation of 1,6,7-trisubstituted azabenzimidazoles as kinase inhibitors |
| 01/04/2007 | US20070004718 Ion channel modulating compounds and uses thereof |
| 01/04/2007 | US20070004710 6-({2-[4-(6-Methoxy-[1,5]naphthyridin-4-yl)phenyl]ethylamino}methyl)-4H-pyrido[3,2-b][1,4]thiazin-3-one;bacterial infections; antibiotic resistance; Staphylococcus aureus, Streptococcus pneumoniae and pyogenes, Enterococcus; Haemophilus influenzae, Moraxella catarrhalis, E-coli |
| 01/04/2007 | US20070004703 Use of 1-(dialkoxyphenylsulfonyl)-3-(pyrrolidino)-3-(phenyl)indolin-2-one compounds to treat hypertension, cardiovascular disorders, central nervous system disorders, psychological disorders, gastrointestinal disorders; affinity for V1b and V1a receptors of arginine-vasopressin |
| 01/04/2007 | US20070004688 Mixture with surfactant; bone disorders; controlling immunology response; cancer therapy |
| 01/04/2007 | US20070004687 Use of dipyridamole in combination with acetylsalicylic acid and an angiotensin ll antagonist for stroke prevention |
| 01/04/2007 | US20070004657 Diagnosis and treatment of kidney fibrosis and other fibrotic diseases |
| 01/04/2007 | US20070004039 Immortalized hepatocytes |
| 01/04/2007 | US20070004012 Reacting chondroitin disaccharide with a recombinantly produced 2-O sulfatase; using 2-O sulfatase for degrading and analyzing glycosaminoglycans (GAGs) present in a sample |
| 01/04/2007 | US20070003645 Butyrospermum-triterpene fraction containing lupeol; alpha -amyrin and/or beta amyrin, and butyrospermol; plant extract |
| 01/04/2007 | US20070003548 Anti-TNF antibodies, compositions, methods and uses |
| 01/04/2007 | US20070003519 reducing ICT1024 expression; inhibitor is an siRNA, shRNA, antisense RNA, antisense DNA, decoy molecule, decoy DNA, double stranded DNA, single-stranded DNA, complexed DNA, encapsulated DNA, viral DNA, plasmid DNA, naked RNA, encapsulated RNA, viral RNA, double stranded RNA, RNA interference; cancer |
| 01/04/2007 | DE112004002099T5 Anionen bindende Polymere und Verwendungen davon Anion-binding polymers and uses thereof |
| 01/03/2007 | EP1737882A1 Peptide inhibitors of metalloproteinase activity |
| 01/03/2007 | EP1737854A1 NOVEL 2-(1-AZA-BICYCLO[2.2.2]OCT-3-yl)-2,3-DIHYDROISOINDOL-l-ONE/5,6-DIHYDRO-FURO[2,3-c]PYRROL-4ONE DERIVATIVES LIGANDS FOR ALPHA 7 NICOTINIC ACETYLCHOLINE RECEPTOR |
| 01/03/2007 | EP1737425A1 Composition comprising colony stimulating factor for treatment of a localised bacterial infection and bacterial related disease |
| 01/03/2007 | EP1572099A4 Screening and therapeutic methods relating to neurogenesis |
| 01/03/2007 | EP1093379B1 Use of inhibitors of protein kinase c epsilon to treat pain |
| 01/03/2007 | CN1890362A Branched sulfates with improved odor properties and their use in personal care compositions |
| 01/03/2007 | CN1889967A Nutraceutical mangosteen tea |
| 01/03/2007 | CN1889950A The use of urocanic acid being able to acidify the cell cytoplasm and for preventing or halting cellular proliferation in a person |
| 01/03/2007 | CN1889944A Treatment of diseases involving ErbB2 kinase overexpression |
| 01/03/2007 | CN1889943A Synergistic anti-cancer compounds |
| 01/03/2007 | CN1292796C Controlled release composition and method of producing the same |
| 01/02/2007 | US7157493 Fermentation of green tea extract; antilipemic agents; cardiovascular disorders; anticholesterol agents |
| 01/02/2007 | US7157480 Use of pramipexole to treat amyotrophic lateral sclerosis |
| 01/02/2007 | US7157461 For therapy of hypertension |
| 01/02/2007 | US7157446 Complex of ras-farnesyltransferase inhibitor, a cyclodextrin, and ethanol |
| 01/02/2007 | US7157275 growing adherent cells using a cell adhesion promoting ("CAP") peptide covalently coupled to a cell adhesion resistant layer such as hyaluronic acid on a polystyrene surface to promote cell attachment, growth differentiation, in culture; biological scaffolds |
| 01/02/2007 | CA2436275C Polymeric delivery formulations of leuprolide with improved efficacy |
| 01/02/2007 | CA2400578C Controlled-release compositions containing opioid agonist and antagonist |
| 12/28/2006 | WO2006041409A8 Medical solution, method for producing and use thereof |
| 12/28/2006 | WO2006031191A8 Compositions comprising compounds capable of forming a reversible bond or association with gaseous nitric oxide |
| 12/28/2006 | WO2005058243A3 Methods for treating cancer using vascular endothelial cell growth inhibitor vegi-192a |
| 12/28/2006 | WO2005041904A3 Inhibitors of coronavirus protease and methods of use thereof |
| 12/28/2006 | WO2005030142A8 Rifalazil formulations |
| 12/28/2006 | WO2005011606A3 System and method for the photodynamic treatment of burns, wounds, and related skin disorders |
| 12/28/2006 | WO2005009337A3 Treating severe acute respiratory syndrome |
| 12/28/2006 | US20060294601 Compositions, organisms and methodologies employing a novel human kinase |
| 12/28/2006 | US20060293509 Water-soluble chitosan having low endotoxin concentration and methods for making and using the same |
| 12/28/2006 | US20060293380 Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease |
| 12/28/2006 | US20060293347 Pharmaceutically active compounds |
| 12/28/2006 | US20060293342 Tie-2 modulators and methods of use |
| 12/28/2006 | US20060293339 Biaryl substituted 6-membered heterocycles as sodium channel blockers |
| 12/28/2006 | US20060293239 Treatment and Diagnosis of Insulin-Resistant States |
| 12/28/2006 | US20060292673 For degradation of glycosaminoglycans; inhibiting angiogenesis and cellular proliferation; treating cancer, neurodegenerative disease, atherosclerosis and microbial infection |
| 12/28/2006 | US20060292655 2-O sulfatase compositions and methods of analyzing therewith |
| 12/28/2006 | US20060292563 Methods of diagnosing & treating diabetes and insulin resistance |
| 12/28/2006 | US20060292551 cationic peptides useful in the treatment of dermatitis and viral infections; for topical administration |
| 12/28/2006 | US20060292224 Pharmaceutical composition |
| 12/28/2006 | US20060292130 2-O sulfatase nucleic acid compositions |
| 12/28/2006 | US20060292115 Methods and compositions for treating and preventing inflammatory conditions |
| 12/28/2006 | US20060292083 Inhalation compositions with high drug ratios |
| 12/27/2006 | EP1736478A1 Methods and compositions for treating flaviviruses and pestiviruses |
| 12/27/2006 | EP1608317A4 Dipeptidyl peptidase inhibitors |
| 12/27/2006 | EP1597260B1 Triazole compounds useful in therapy |
| 12/27/2006 | EP1427423B1 Benzothiazepine and benzothiadiazepine derivatives with ileal bile acid transport (ibat) inhibitory activity for the treatment hyperlipidaemia |
| 12/27/2006 | EP1280912B1 Isolation and characterization of the csa operon (etec-cs4 pili) and methods of using same |
| 12/27/2006 | EP1021410B1 Prostaglandin agonists and their use to treat bone disorders |
| 12/27/2006 | EP0918458B1 Antimicrobial treatment for herpes simplex virus and other infectious diseases |
| 12/27/2006 | CN1886400A 9, 10-alpha, alpha-OH-taxane analogs and methods for production thereof |
| 12/27/2006 | CN1886398A Thioether-substituted benzamides as inhibitors of factor Xa |
| 12/27/2006 | CN1886397A 3-heterocyclyl-indole derivatives as inhibitors of glycogen synthase kinase-3 (gsk-3) |
| 12/27/2006 | CN1886367A Fused ring dicationic anti-protozoan agents and their prodrugs |
| 12/27/2006 | CN1886164A Package for pharmaceutical formulation |
| 12/27/2006 | CN1886130A Use of 2-thia-dibenzo[e, h]azulenes for the manufacture of pharmaceutical formulations for the treatment and prevention of central nervous system diseases and disorders |
| 12/27/2006 | CN1886128A Compositions and methods for treating burns |
| 12/27/2006 | CN1886122A Compounds and methods for treating and preventing exercise-induced cardiac arrhythmias |
| 12/27/2006 | CN1886117A Pharmaceutical compositions |
| 12/26/2006 | US7153825 Administering an exendin modified with a polyethylene glycol, gelatin and/or albumin to increase its biological half-life; treating hyperglucagonemia and diabetes, especially type II diabetes |
| 12/26/2006 | US7153659 Bioassay for measuring the proliferation of T-cells in Human papiloma virus |
| 12/21/2006 | WO2006135796A2 Crystalline forms of a pyrrolotriazine compound |